Is IPCIF or VYM a better dividend investment in 2026?

IPCIF currently yields 1333.33% with a 5% 5-year dividend growth rate. VYM yields 2.41% with 7.8% growth. The better choice depends on your goal: IPCIF offers higher current income.

What is the dividend yield difference between IPCIF and VYM?

IPCIF has a forward dividend yield of 1333.33% ($2.00/share annually). VYM yields 2.41% ($3.51/share annually). The yield gap is 1330.92 percentage points.

Home › Compare › IPCIF vs VYM

IPCIF vs VYM: Dividend Comparison 2026

IPCIF yields 1333.33% · VYM yields 2.41%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IPCIF wins by $241528700.58M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IPCIF

● Live price

1333.33%

Share price

$0.15

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$241528700.61M

Annual income

$210,475,860,072,406.56

Full IPCIF calculator →

VYM

Vanguard High Dividend Yield ETF

● Live price

2.41%

Share price

$145.48

Annual div

$3.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$278.55

Full VYM calculator →

Portfolio growth — IPCIF vs VYM

📍 IPCIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IPCIF	VYM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IPCIF + VYM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IPCIF pays

VYM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IPCIF

Annual income on $10K today (after 15% tax)

$113,333.33/yr

After 10yr DRIP, annual income (after tax)

$178,904,481,061,545.56/yr

VYM

Annual income on $10K today (after 15% tax)

$205.23/yr

After 10yr DRIP, annual income (after tax)

$236.77/yr

At 15% tax rate, IPCIF beats the other by $178,904,481,061,308.78/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IPCIF + VYM for your $10,000?

IPCIF: 50%VYM: 50%

100% VYM50/50100% IPCIF

Portfolio after 10yr

$120764350.32M

Annual income

$105,237,930,036,342.55/yr

Blended yield

87.14%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IPCIF buys

VYM buys

Politician	Chamber	Ticker	Type	Amount	Date
Carol Devine Miller	🏢 House	$VYM	▲ Buy	$15,001 - $50,000	2022-11-02

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIPCIFVYM

Forward yield	1333.33% ✓	2.41%
Annual dividend / share	$2.00	$3.51 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$241528700.61M ✓	$27.8K
Annual income after 10y	$210,475,860,072,406.56 ✓	$278.55
Total dividends collected	$239239876.27M ✓	$2.6K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: IPCIF vs VYM ($10,000, DRIP)

Year	IPCIF Portfolio	IPCIF Income/yr	VYM Portfolio	VYM Income/yr	Gap
1← crossover	$144,033	$133,333.33	$11,151	$241.44	+$132.9K → IPCIF
2	$1,948,924	$1,794,807.89	$12,413	$246.79	+$1.94M → IPCIF
3	$24,782,219	$22,696,870.86	$13,794	$251.79	+$24.77M → IPCIF
4	$296,245,945	$269,728,970.81	$15,306	$256.47	+$296.23M → IPCIF
5	$3,330,378,004	$3,013,394,842.54	$16,960	$260.84	+$3330.36M → IPCIF
6	$35,223,684,321	$31,660,179,856.69	$18,768	$264.92	+$35223.67M → IPCIF
7	$350,636,384,108	$312,947,041,885.16	$20,745	$268.71	+$350636.36M → IPCIF
8	$3,286,630,500,315	$2,911,449,569,318.85	$22,905	$272.24	+$3286630.48M → IPCIF
9	$29,021,346,295,663	$25,504,651,660,325.88	$25,265	$275.51	+$29021346.27M → IPCIF
10	$241,528,700,608,766	$210,475,860,072,406.56	$27,842	$278.55	+$241528700.58M → IPCIF

IPCIF vs VYM: Complete Analysis 2026

IPCIF — Stock

Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for hyperactivity disorder; Keppra XR, a levetiracetam extended-release tablet for the treatment of partial onset seizures in patients with epilepsy; Effexor XR, a venlafaxine hydrochloride extended-release capsule to treat depression; and Protonix, a pantoprazole sodium delayed-release tablet to treat gastroesophageal reflux disease. It also provides Glucophage XR, a metformin hydrochloride extended-release tablet that treats type 2 diabetes; Seroquel XR, a quetiapine fumarate extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorders; Lamictal XR, a lamotrigine extended release tablet to treat epilepsy; Pristiq, a desvenlafaxine extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; and Ranexa, a ranolazine extended release tablet for chronic angina. In addition, the company is developing OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Regabatin XR, a pregabalin extended-release capsule for the management of neuropathic pain. It has a license and commercialization agreement with Par Pharmaceutical Inc. The company was founded in 1998 and is based in Toronto, Canada.

Full IPCIF Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →

📬

Get this IPCIF vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IPCIF vs SCHD IPCIF vs JEPI IPCIF vs O IPCIF vs KO IPCIF vs MAIN IPCIF vs VIG IPCIF vs DGRO IPCIF vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.